Home LiteratureArticle Details
PMID: 11588178 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Induction of alpha-synuclein aggregation by intracellular nitrative insult.

Paxinou E, Chen Q, Weisse M, Giasson BI, Norris EH, Rueter SM, Trojanowski JQ, Lee VM, Ischiropoulos H

Abstract

Brain lesions containing filamentous and aggregated alpha-synuclein are hallmarks of neurodegenerative synucleinopathies. Oxidative stress has been implicated in the formation of these lesions. Using HEK 293 cells stably transfected with wild-type and mutant alpha-synuclein, we demonstrated that intracellular generation of nitrating agents results in the formation of alpha-synuclein aggregates. Cells were exposed simultaneously to nitric oxide- and superoxide-generating compounds, and the intracellular formation of peroxynitrite was demonstrated by monitoring the oxidation of dihydrorhodamine 123 and the nitration of alpha-synuclein. Light microscopy using antibodies against alpha-synuclein and electron microscopy revealed the presence of perinuclear aggregates under conditions in which peroxynitrite was generated but not when cells were exposed to nitric oxide- or superoxide-generating compounds separately. alpha-Synuclein aggregates were observed in 20-30% of cells expressing wild-type or A53T mutant alpha-synuclein and in 5% of cells expressing A30P mutant alpha-synuclein. No evidence of synuclein aggregation was observed in untransfected cells or cells expressing beta-synuclein. In contrast, selective inhibition of the proteasome resulted in the formation of aggregates detected with antibodies to ubiquitin in the majority of the untransfected cells and cells expressing alpha-synuclein. However, alpha-synuclein did not colocalize with these aggregates, indicating that inhibition of the proteasome does not promote alpha-synuclein aggregation. In addition, proteasome inhibition did not alter the steady-state levels of alpha-synuclein, but addition of the lysosomotropic agent ammonium chloride significantly increased the amount of alpha-synuclein, indicating that lysosomes are involved in degradation of alpha-synuclein. Our data indicate that nitrative and oxidative insult may initiate pathogenesis of alpha-synuclein aggregates.

MeSH Terms
Ammonium Chloride/metabolism,pharmacokinetics Cell Line Cysteine Endopeptidases Enzyme Inhibitors/pharmacology Humans Inclusion Bodies/metabolism Intracellular Fluid/metabolism Kidney/cytology,drug effects,metabolism Lysosomes/metabolism Macromolecular Substances Multienzyme Complexes/antagonists & inhibitors Nerve Tissue Proteins/genetics,metabolism Neurodegenerative Diseases/metabolism Nitrates/metabolism Nitric Oxide/biosynthesis,pharmacology Oxidants/pharmacology Proteasome Endopeptidase Complex Protein Binding/drug effects,physiology Superoxides/metabolism,pharmacology Synucleins Transfection Ubiquitins/metabolism alpha-Synuclein beta-Synuclein
Chemicals
Enzyme Inhibitors Macromolecular Substances Multienzyme Complexes Nerve Tissue Proteins Nitrates Oxidants SNCA protein, human SNCB protein, human Synucleins Ubiquitins alpha-Synuclein beta-Synuclein Ammonium Chloride Superoxides peroxynitric acid Nitric Oxide Cysteine Endopeptidases Proteasome Endopeptidase Complex
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Paxinou E
Stokes Research Institute and Department of Biochemistry and Biophysics, Children's Hospital of Philadelphia and The University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Chen Q
Weisse M
Giasson B I
Norris E H
Rueter S M
Trojanowski J Q
Lee V M
Ischiropoulos H
References (61)
61 references, click to expand
  1. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
    J Neurosci. 1992 May;12(5):1658-67 PMID: 1578260
  2. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.
    Proc Natl Acad Sci U S A. 1996 May 14;93(10):4565-71 PMID: 8643444
  3. Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    J Neurochem. 2001 Jan;76(2):637-40 PMID: 11208927
  4. Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult.
    J Neurochem. 2001 Feb;76(4):998-1009 PMID: 11181819
  5. Widespread peroxynitrite-mediated damage in Alzheimer's disease.
    J Neurosci. 1997 Apr 15;17(8):2653-7 PMID: 9092586
  6. MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons.
    Neuroreport. 2000 Jan 17;11(1):211-3 PMID: 10683860
  7. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation.
    J Neurosci. 1998 Oct 15;18(20):8126-32 PMID: 9763459
  8. Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice.
    J Neurosci. 1997 Sep 15;17(18):6908-17 PMID: 9278526
  9. Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies.
    J Biol Chem. 2000 Jun 16;275(24):18344-9 PMID: 10747881
  10. Cysteine proteinase inhibitors and ras gene products share the same biological activities including transforming activity toward NIH3T3 mouse fibroblasts and the differentiation-inducing activity toward PC12 rat pheochromocytoma cells.
    Carcinogenesis. 1990 Jan;11(1):75-80 PMID: 2403861
  11. Degradation of alpha-synuclein by proteasome.
    J Biol Chem. 1999 Nov 26;274(48):33855-8 PMID: 10567343
  12. Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease.
    J Biol Chem. 1999 Dec 3;274(49):34621-8 PMID: 10574926
  13. Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease.
    J Biol Chem. 1999 Oct 8;274(41):28849-52 PMID: 10506125
  14. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis.
    Hum Mol Genet. 2001 Apr 15;10(9):919-26 PMID: 11309365
  15. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.
    Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1956-61 PMID: 8700866
  16. Neuropathology of synuclein aggregates.
    J Neurosci Res. 2000 Jul 15;61(2):121-7 PMID: 10878583
  17. Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway.
    J Neurosci. 1996 Jan;16(1):253-61 PMID: 8613791
  18. A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease.
    J Neurosci Res. 2000 Feb 15;59(4):528-33 PMID: 10679792
  19. alpha-synuclein promotes mitochondrial deficit and oxidative stress.
    Am J Pathol. 2000 Aug;157(2):401-10 PMID: 10934145
  20. Two distinct mechanisms of nitric oxide-mediated neuronal cell death show thiol dependency.
    Am J Physiol Cell Physiol. 2000 Jun;278(6):C1099-107 PMID: 10837337
  21. Neuropathology in mice expressing human alpha-synuclein.
    J Neurosci. 2000 Aug 15;20(16):6021-9 PMID: 10934251
  22. Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro.
    J Biol Chem. 1999 Mar 19;274(12):7619-22 PMID: 10075647
  23. Cold-induced brain edema and infarction are reduced in transgenic mice overexpressing CuZn-superoxide dismutase.
    Ann Neurol. 1991 May;29(5):482-6 PMID: 1859179
  24. The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity.
    J Neurosci. 2000 Aug 15;20(16):6048-54 PMID: 10934254
  25. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.
    Science. 2000 Feb 18;287(5456):1265-9 PMID: 10678833
  26. Protein nitration in Parkinson's disease.
    J Neuropathol Exp Neurol. 1998 Apr;57(4):338-42 PMID: 9600227
  27. Intraneuronal filamentous tau protein and alpha-synuclein deposits in neurodegenerative diseases.
    Biochem Soc Trans. 1998 Aug;26(3):463-71 PMID: 9765897
  28. A beta-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line.
    Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3358-62 PMID: 8159752
  29. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
    Science. 2000 Nov 3;290(5493):985-9 PMID: 11062131
  30. Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein.
    J Biol Chem. 2000 Jan 7;275(1):390-7 PMID: 10617630
  31. Synergistic interactions between NADPH-cytochrome P-450 reductase, paraquat, and iron in the generation of active oxygen radicals.
    Biochem Pharmacol. 1989 Jun 1;38(11):1779-86 PMID: 2500125
  32. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.
    Cell. 1994 Sep 9;78(5):761-71 PMID: 8087844
  33. Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity.
    Hum Mol Genet. 2000 Nov 1;9(18):2683-9 PMID: 11063727
  34. Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation.
    Neuroscience. 2000;97(2):279-84 PMID: 10799759
  35. Detection of reactive nitrogen species using 2,7-dichlorodihydrofluorescein and dihydrorhodamine 123.
    Methods Enzymol. 1999;301:367-73 PMID: 9919585
  36. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies.
    Am J Pathol. 2000 Nov;157(5):1439-45 PMID: 11073803
  37. Quinones increase gamma-glutamyl transpeptidase expression by multiple mechanisms in rat lung epithelial cells.
    Am J Physiol. 1998 Mar;274(3):L330-6 PMID: 9530167
  38. Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss.
    Brain Res. 1999 Mar 27;823(1-2):1-10 PMID: 10095006
  39. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.
    J Neurosci. 2000 Dec 15;20(24):9207-14 PMID: 11124998
  40. The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity.
    J Biol Chem. 2000 Dec 8;275(49):38581-8 PMID: 10969076
  41. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria.
    Biochem J. 1980 Nov 1;191(2):421-7 PMID: 6263247
  42. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase.
    Science. 1994 Sep 23;265(5180):1883-5 PMID: 7522345
  43. Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins.
    J Enzyme Inhib. 1990;3(3):195-201 PMID: 2079636
  44. Kinetics of peroxynitrite reaction with amino acids and human serum albumin.
    J Biol Chem. 1999 Jan 8;274(2):842-8 PMID: 9873023
  45. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7659-63 PMID: 9636206
  46. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy.
    Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):571-6 PMID: 10639120
  47. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice.
    J Neurosci. 1996 Apr 15;16(8):2479-87 PMID: 8786424
  48. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species.
    Arch Biochem Biophys. 1998 Aug 1;356(1):1-11 PMID: 9681984
  49. Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation.
    J Neurosci. 1998 Feb 1;18(3):923-31 PMID: 9437014
  50. Sensitization of neuronal cells to oxidative stress with mutated human alpha-synuclein.
    J Neurochem. 2000 Dec;75(6):2546-54 PMID: 11080208
  51. Diazeniumdiolates: pro- and antioxidant applications of the "NONOates".
    Free Radic Biol Med. 2000 May 15;28(10):1463-9 PMID: 10927170
  52. Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells.
    Neurosci Lett. 2000 May 12;285(2):79-82 PMID: 10793231
  53. Peroxynitrite-mediated oxidation of dihydrorhodamine 123.
    Free Radic Biol Med. 1994 Feb;16(2):149-56 PMID: 8005510
  54. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease.
    Trends Neurosci. 1998 Jun;21(6):249-54 PMID: 9641537
  55. Aggresomes: a cellular response to misfolded proteins.
    J Cell Biol. 1998 Dec 28;143(7):1883-98 PMID: 9864362
  56. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage.
    J Neurosci. 1999 Jul 15;19(14):5910-8 PMID: 10407030
  57. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons.
    Proc Natl Acad Sci U S A. 1994 May 10;91(10):4155-9 PMID: 7910402
  58. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.
    Nat Med. 1999 Dec;5(12):1403-9 PMID: 10581083
  59. Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation.
    Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4897-902 PMID: 10781096
  60. Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
    Nat Neurosci. 2000 Dec;3(12):1301-6 PMID: 11100151
  61. A Drosophila model of Parkinson's disease.
    Nature. 2000 Mar 23;404(6776):394-8 PMID: 10746727
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
1529-2401
Published
2001-10-15
Pages
8053-61
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC6763872
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]